|
⚲
|
| Keyboard |
| Scopia Capital Management LP
✚
|
|
|---|---|
| CRD # | 124403 |
| SEC # | 801-61668 |
| CIK # | 0001279150 |
| AUM | 587.3 M (2026-04-01) |
| Employees | 20 (45% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-370-0303 |
| Address | 152 West 57th Street New York, NY 10019 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5 – Fees and Compensation As a general matter, the Adviser or an affiliate is paid an asset-based management fee and receives performance-based compensation (detailed in Item 6 below). The Adviser deducts asset-based management fees from each Scopia Fund’s assets. Asset-based management fees generally range from 1.0% to 1.5% per annum of the net assets of investors in the Hedge Funds, and from 0.75% to 1.0% per annum of net assets of investors in the Long- Only Fund. Management fees for investors in the Scopia Funds are charged on a quarterly basis in advance based on the value of the assets as of the first day of the calendar quarter. The management fee may be reduced by 0.25% annually for investors in the Hedge Funds if the investor, or the consultancy firm which has directed the investor, maintains invested assets exceeding a certain amount, has been invested for a specified period of time or agrees to remain invested for a specified period of time, and the Adviser maintains a certain aggregate value of the net assets of the Scopia Funds. The Adviser has complete authority to determine, in each case, whether an investor is eligible for a reduced management fee and the Adviser’s decision in that regard shall be final and binding on the investor. If the Adviser does not manage a Scopia Fund for a full quarter, the asset-based management fee charged to such Scopia Fund will be pro-rated for such period. To the extent that fees are negotiable, the investors in a Scopia Fund may pay more or less than other investors for the same management services, depending, for example, on the relationship to the Adviser, nature of advisory services, account composition and the total client assets under management. The Adviser waives or modifies fees for certain accounts or investors. The Adviser may also reduce management fees in connection with fees and other income earned from services related to the Scopia Funds’ investments including, but not limited to, directors’ fees. The asset-based management fees that are charged to the Legacy Sub-Account are set forth in the Adviser’s trading advisory agreement with the Legacy Sub-Account. The asset-based management fees that are charged to Windmill are set forth in Windmill’s offering and governing documents. The First Loss Fund and SCIP2 are not charged asset-based management fees. A third-party administrator to the Scopia Funds and Windmill calculates the asset-based management fees of the Scopia Funds and Windmill. To mitigate conflicts of interest regarding over-valuing such accounts to increase fees, or conceal poor performance, the Adviser maintains a policy regarding valuation of securities and uses independent third-party services to price the securities in the accounts of the Scopia Funds and Windmill, when applicable. The administration and calculation of asset-based management fees in respect of the Legacy Sub-Account is overseen by the respective sponsors of such funds/accounts. In addition to paying asset-based management fees, if any, Scopia Funds are also subject to other expenses in accordance with the fund governing documents including, but not limited to (as applicable): (i) transaction costs and investment related expenses incurred in connection with the Scopia Fund’s trading activities, including brokerage, research expenses (excluding research-related travel), clearing, margin interest (if any), and custodial expenses; (ii) routine legal, accounting, auditing, tax preparation, administration, outside directors, and related fees and expenses; (iii) licensing, development and monitoring fees and expenses related to risk management, including portfolio analysis application fees and applicable database warehouse fees and expenses; (iv) fees and expenses related to stock loan and treasury systems and applications; (v) the Scopia Fund’s allocable share of applicable insurance premiums; (vi) regulatory compliance-related monitoring and filing fees and expenses (excluding, however, the preparation and filing of Form PF); (vii) expenses associated with the continued offering of interests, which include but are not limited to printing and other solicitation expenses (other than finders’ fees); (viii) all operational, overhead and other expenses of the Scopia Funds including but not limited to, photocopying, facsimile, postage, telephone expenses, and third party valuation services; and (ix) extraordinary expenses (e.g., litigation and settlement costs, disgorgement payments and indemnification obligations), if any. “Research” expenses include, without limitation, research subscriptions, customized research, third party consultant/expert network fees, conference fees and certain research-related technology fees and expenses such as Bloomberg license fees, exchange fees, and order management system fees and expenses (other than compliance-related fees). The Legacy P/E Funds are subject to similar fees in accordance with their governing documents and trading advisory agreement, as applicable. The First Loss Fund is subject to expenses as set forth in the relevant investment advisory agreement. The allocation of expenses by the Adviser between it and any client, and among clients, represents a conflict of interest for the Adviser. To address this conflict, the Adviser has adopted and implemented policies and procedures for the allocation of expenses. Pursuant to these policies and procedures, the Adviser allocates expenses to each client in accordance with the client’s offering and other governing documents or advisory agreement. Client expenses generally will be borne on a pro rata basis (as further described below) among all client portfolios, unless (i) the expense is only relevant to a particular client portfolio, in which case it will be allocated solely thereto, or (ii) the Adviser believes that deviating from pro rata allocations would be fair, reasonable and equitable given the nature of the expense or client ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7 – Types of Clients The Adviser provides investment advisory services on a discretionary basis to its clients including the Fund Clients and the Legacy P/E Funds, which are intended for institutional and other sophisticated investors. Any initial and additional subscription minimums are disclosed in the applicable offering memorandum and other governing documents. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Corteva Inc | 0.0 | ||
| Chemours Co | 0.0 | ||
| Commscope Holding Company Inc | 0.0 | ||
| Livanova PLC | 0.0 | ||
| Amazon Com Inc | 0.0 | ||
| Primo Brands Corp | 0.0 | ||
| KKR & Co LP | 0.0 | ||
| Regal Beloit Corp | 0.0 | ||
| Hunt J B Transport Services Inc | 0.0 | ||
| Peloton Interactive Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Scopia SPV Opportunity A LLC | [2023-11-28] | 18.2 M | |
| Filed 2023-06-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | Scopia Long QP LLC | [2016-03-30] | 565.4 M | 64.9 M |
| Filed 2025-10-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Scopia HCM Partners LLC | [2015-11-27] | 13.6 M | 43.7 M |
| Filed 2015-08-14 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | Scopia Health Care International Master Fund LP | 2015-08-28 | 442.7 M | |
| HF | Scopia Health Care LLC | [2015-08-28] | 71.4 M | 92.8 M |
| Filed 2018-05-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Scopia Long International Master Fund LP | 2015-03-31 | 26.4 M | |
| PE | Scopia Co-Investment Partners 2 LLC | 2014-03-31 | 136.1 M | |
| HF | Scopia LB International Master Fund LP | [2014-03-31] | 5.0 M | 78.7 M |
| Filed 2018-01-12 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Scopia LB LLC | [2014-03-31] | 97.2 M | 87.8 M |
| Filed 2019-01-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Scopia Emerging Managers LLC | [2012-03-30] | 3.0 M | 7.8 M |
| Offered $3,000,000 · Filed 2013-09-17 (D/A) · Exemption 506, 3(c), 3(c)(7) · Minimum $1,000 · Duration One year or less · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 0.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 0.6 |
| By Discretionary | ||
| Discretionary | 6 | 0.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 0.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.2 | |
| United States Persons | 0.4 | |
| Total | 6 | 0.6 |
| Limited Partners | 2011 - 2026 |
|---|---|
| New Jersey Division of Investment | |
| State Board of Administration of Florida |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| James Keyes | Director | 153 | 31 | |
| Ian Pilgrim | Director | 148 | 19 | |
| Scopia Capital Management LP | Executive Officer | 14 | 2 | |
| Matthew Sirovich | Director, Executive Officer | 11 | 2 | |
| Jeremy Mindich | Executive Officer | 11 | 2 | |
| Scopia Capital GP LLC | Executive Officer | 10 | 2 | |
| Scopia Capital Managment LP | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001279150] | |
| 3 | [0001279150] | |
| 4 | [0001279150] | |
| SC 13D | [0001279150] | |
| SC 13G | [0001279150] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $5.1B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300GE4E8GIYNWBX20 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Scopia Management Inc | |
| Sirovich Matthew | |
| Itron Inc | |
| Mindich Jeremy | |
| Scopia Capital Management LP | |
| Acorda Therapeutics Inc | |
| PHH Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Itron Inc ITRI
Common Stock
|
2019-05-28 | Sell | 31,144 | $57.34 | 1,785,797 |
|
Itron Inc ITRI
Common Stock
|
2019-05-24 | Sell | 17,272 | $57.31 | 989,858 |
|
Itron Inc ITRI
Common Stock
|
2019-05-23 | Sell | 31,123 | $56.38 | 1,754,715 |
|
Itron Inc ITRI
Common Stock
|
2019-05-22 | Sell | 21,206 | $57.47 | 1,218,709 |
|
Itron Inc ITRI
Common Stock
|
2019-05-21 | Sell | 33,880 | $57.43 | 1,945,728 |
|
Itron Inc ITRI
Common Stock
|
2019-05-07 | Sell | 8,203 | $63.47 | 520,644 |
|
Itron Inc ITRI
Common Stock
|
2019-05-06 | Sell | 28,336 | $53.07 | 1,503,792 |
|
Itron Inc ITRI
Common Stock
|
2019-05-03 | Sell | 30,271 | $52.77 | 1,597,401 |
|
Itron Inc ITRI
Common Stock
|
2019-05-02 | Sell | 36,777 | $53.65 | 1,973,086 |
|
Itron Inc ITRI
Common Stock
|
2019-05-01 | Sell | 32,317 | $52.74 | 1,704,399 |
|
Itron Inc ITRI
Common Stock
|
2019-04-30 | Sell | 25,808 | $53.42 | 1,378,663 |
|
Itron Inc ITRI
Common Stock
|
2019-04-29 | Sell | 16,055 | $52.52 | 843,209 |
|
Itron Inc ITRI
Common Stock
|
2019-04-26 | Sell | 17,097 | $51.77 | 885,112 |
|
Itron Inc ITRI
Common Stock
|
2019-04-25 | Sell | 11,544 | $50.67 | 584,934 |
|
Itron Inc ITRI
Common Stock
|
2019-04-24 | Sell | 14,284 | $51.74 | 739,054 |
|
Itron Inc ITRI
Common Stock
|
2019-04-23 | Sell | 16,311 | $51.12 | 833,818 |
|
Itron Inc ITRI
Common Stock
|
2019-04-18 | Sell | 13,757 | $50.05 | 688,538 |
|
Itron Inc ITRI
Common Stock
|
2019-04-17 | Sell | 22,154 | $50.30 | 1,114,346 |
|
Itron Inc ITRI
Common Stock
|
2019-04-16 | Sell | 20,179 | $49.62 | 1,001,282 |
|
Itron Inc ITRI
Common Stock
|
2019-04-15 | Sell | 35,245 | $48.59 | 1,712,555 |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Callodine Credit Management LLC
✚
|
MA | 603.0 M |
|
Endeavour Capital Advisors Inc
✚
|
CT | 602.7 M |
|
GFG Alternative Investment Advisors LLC
✚
|
CT | 599.6 M |
|
Octahedron Capital Management LP
✚
|
CA | 594.2 M |
|
Atlas Merchant Capital LLC
✚
|
NY | 593.0 M |
|
Inclusive Capital Partners LP
✚
|
CA | 591.1 M |
|
Virage Capital Management LP
✚
|
TX | 588.3 M |
|
Civitas Capital Management LLC
✚
|
TX | 578.6 M |
|
Angeleno Group LLC
✚
|
CA | 576.5 M |
|
Gumshoe Capital Management LLC
✚
|
NY | 570.6 M |